Damora Therapeutics (DMRA) Change in Acquisitions & Divestments (2021 - 2024)

Damora Therapeutics has reported Change in Acquisitions & Divestments for 4 years, with the latest figure at $6.0 million in Q2 2024.

• For the quarter ending Q2 2024, Change in Acquisitions & Divestments fell 51.35% year-over-year to $6.0 million; the trailing twelve-month figure through Dec 2024 stood at $11.6 million (down 75.82% YoY), and the FY2024 full-year result was $11.6 million, down 75.82% from the prior year.
• Change in Acquisitions & Divestments for Q2 2024 stood at $6.0 million, up from $5.6 million in the prior quarter.
• The five-year high for Change in Acquisitions & Divestments was $18.6 million in Q4 2022, with the low at $5.6 million in Q1 2024.
• Historically, Change in Acquisitions & Divestments has averaged $11.8 million across 4 years, with a median of $12.3 million in 2023.
• Annual changes were most pronounced in 2023 — Change in Acquisitions & Divestments jumped 44.71% — and 2024, when it sank 60.0%.
• Damora Therapeutics' Change in Acquisitions & Divestments stood at $14.4 million in 2021, then increased by 28.96% to $18.6 million in 2022, then plunged by 48.89% to $9.5 million in 2023, then plunged by 36.82% to $6.0 million in 2024.
• The last three Change in Acquisitions & Divestments figures came in at $6.0 million (Q2 2024), $5.6 million (Q1 2024), and $9.5 million (Q4 2023), per Business Quant data.